5% Dextrose and 0.9% Sodium Chloride Injection USP 9 mg (Sodium Chloride SOLUTION) 9 MG

5% Dextrose and 0.9% Sodium Chloride Injection USP is a sterile intravenous solution combining dextrose and sodium chloride. It is commonly used for hydration and electrolyte replenishment, suitable for medical settings.

Strength

9 MG

Pack Size

1000ML

Manufacturer / TM Owner

B. BRAUN MEDICAL INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

This intravenous solution is primarily used to provide hydration and maintain electrolyte balance. It may be administered to patients who require fluid replacement or to support nutritional needs. The combination of dextrose and sodium chloride helps to address both energy requirements and electrolyte deficiencies.

Side Effects

When administered intravenously, this solution helps to restore fluid balance and provide essential electrolytes. It may also contribute to maintaining blood pressure and supporting overall hydration. The effects are typically observed shortly after administration.

Precautions & Warnings

This solution should be administered under medical supervision. It is important to monitor patients for any signs of adverse reactions. Proper aseptic techniques should be followed to prevent contamination. Always check the solution for any particles or discoloration before use.

Avoid Interactions

This solution may interact with other medications or treatments. It is important to inform healthcare providers about all current medications. Specific interactions with other intravenous solutions or drugs should be discussed with a healthcare professional.

Frequently Asked Questions

This solution is used for hydration and electrolyte replenishment, often in medical settings.

This solution is administered intravenously, typically under medical supervision.

The solution helps restore fluid balance and provide essential electrolytes, supporting hydration and blood pressure.

Yes, it should be administered under medical supervision and monitored for any adverse reactions.

Yes, it may interact with other medications or treatments, so it's important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.